L264-0601 Screening compound: N-[5-(4-cyclohexylbenzenesulfonamido)-1,3-benzothiazol-2-yl]cyclohexanecarboxamide

L264-0601 Screening compound: N-[5-(4-cyclohexylbenzenesulfonamido)-1,3-benzothiazol-2-yl]cyclohexanecarboxamide
L264-0601 Screening compound: N-[5-(4-cyclohexylbenzenesulfonamido)-1,3-benzothiazol-2-yl]cyclohexanecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L264-0601
N-[5-(4-cyclohexylbenzenesulfonamido)-1,3-benzothiazol-2-yl]cyclohexanecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L264-0601

Molecular Formula

C26H31N3O3S2 (C26 H31 N3 O3 S2)

Compound Name

N-[5-(4-cyclohexylbenzenesulfonamido)-1,3-benzothiazol-2-yl]cyclohexanecarboxamide

IUPAC name

N-[5-(4-cyclohexylbenzenesulfonamido)-13-benzothiazol-2-yl]cyclohexanecarboxamide

SMILES

O=C(C1CCCCC1)Nc1nc(cc(cc2)NS(c3ccc(C4CCCCC4)cc3)(=O)=O)c2s1

InChI

InChI=1S/C26H31N3O3S2/c30-25(20-9-5-2-6-10-20)28-26-27-23-17-21(13-16-24(23)33-26)29-34(31,32)22-14-11-19(12-15-22)18-7-3-1-4-8-18/h11-18,20,29H,1-10H2,(H,27,28,30)

InChI Key

MCYABXOFBMBYBU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15121516

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

497.68

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

7.334

Distribution Coefficient, logD

6.751

Water Solubility, LogSw

-5.97

Polar Surface Area

73.853

Acid Dissociation Constant (pKa)

6.95

Base Dissociation Constant (pKb)

3.27

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

46.20

L264-0601 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

ACE2 Library (3043 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CORONAVIRUS Library (20774 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • GPCR
  • Kinases
  • Phosphatases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L264-0601 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L264-0601?
Check Price and Availability of L264-0601, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L264-0601 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L264-0601
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L264-0601
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L264-0601 available by request